Abstract
This study investigated the expression and methylation profiles of SOX2, a stem cell—related transcription factor, in placentas and gestational trophoblastic disease. The methylation status of SOX2 promoter region in 55 hydatidiform moles, 4 choriocarcinoma, 23 first trimester, and 15 term placentas was evaluated by methylation-specific polymerase chain reaction. The methylated allele was found in 4.4% (1/23) of first trimester placentas, 26.7% (4/15) term placentas, and 56.4% (31/55) of hydatidiform moles and all choriocarcinoma samples and cell lines. A significant reduction in SOX2 messenger RNA expression was found in the hydatidiform moles (P = .027) when compared with that in the placentas. SOX2 messenger RNA expression was significantly correlated with SOX2 hypermethylation (P < .001). SOX2 expression was restored in choriocarcinoma cell lines following treatment to 5-Aza-2′ -deoxycytidine and/or Trichostatin A, demethylation and histone deacetylase inhibitors, respectively, and the response was synergistic. Epigenetic mechanisms may play important role on the transcriptional regulation of SOX2 and contribute to pathogenesis of gestational trophoblastic disease.
Similar content being viewed by others
References
Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer. 2006;96(suppl): R26–R30.
Fraga MF, Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle. 2005;4:1377–1381.
Strickland S, Richards WG. Invasion of the trophoblasts. Cell. 1992;71:355–357.
Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003;46:541–556.
Royal College of Obstetricians and Gynaecologists (RCOG). The management of gestational trophoblastic neoplasia (Guideline; no. 38). London, UK: Royal College of Obstetricians and Gyneacologists (RCOG). 2004;1–7.
Sattler HP, Lensch R, Rohde V, et al. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate. 2000;45:207–215.
Wiebe MS, Wilder PJ, Kelly D, et al. Isolation, characterization, and differential expression of the murine Sox2 promoter. Gene. 2000;246:383–393.
Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346:240–244.
Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off. Trends Genet. 2000;16:182–187.
Boer B, Kopp J, Mallanna S, et al. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 2007;35:1773–1786.
Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999;27:1409–1420.
Yuan H, Corbi N, Basilico C, et al. Developmental specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995;9:2635–2645.
Avilion AA, Nicolis SK, Pevny LH, et al. Multipotent cell lineages in early mouse development depend on Sox2 function. Genes Dev. 2003;17:126–140.
Niwa H, Toyooka Y, Shimosato D, et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell. 2005;123:917–929.
Babaie Y, Herwig R, Greber B, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007;25:500–510.
Li J, Pan G, Cui K, et al. A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. J Biol Chem. 2007;282:19481–19492.
Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesion. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract. 5th ed. New York: Springer; 2002:1193–1250.
Paradinas FJ, Elston CW. Gestational trophoblastic disease. Haines and Taylor: Obstetrical and Gynaecological Pathology. In: Fox H, Wells M, eds. Edinburgh: Churchill Livingstone; 2003:1359–1430.
Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17:849–868.
Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol. 2004;17:40–48.
Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004;100:1411–1417.
Ngan HY, Chan KY, Tam KF. Gestational trophoblastic disease. Curr Obstet Gynaecol. 2006;16:93–99.
Xue WC, Feng HC, Tsao SW, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer. 2003;13:879–888.
Xue WC, Chan KY, Feng HC, et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn. 2004;6:326–334.
Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18:1427–1431.
Feng HC, Tsao SW, Ngan HY, et al. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. Histopathology. 2008;52:167–174.
Shen DH, Chan KY, Khoo US, et al. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Carcinogenesis. 2005;26:855–863.
Feng H, Cheung AN, Xue WC, et al. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 2004;94:375–382.
Meng CF, Zhu XJ, Peng G, et al. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. World J Gastroenterol. 2007;13:6166–6171.
Ben-Porath I, Cedar H. Epigenetic crosstalk. Mol Cell. 2001;8:933–935.
Fahrner JA, Eguchi S, Herman JG, et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 2002;62:7213–7218.
Fuks F, Burgers WA, Brehm A, et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 2000;24:88–91.
Rountree MR, Bachman KE, Baylin SB. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet. 2000;25:269–277.
Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21: 5483–5495.
Donadelli M, Costanzo C, Faggioli L, et al. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog. 2003;38:59–69.
Li X, Kato Y, Tsuji Y, et al. The effects of trichostatin a on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts. Cloning Stem Cells. 2008;10:133–142.
Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol. 2007;31:836–845.
Cameron EE, Bachman KE, Myöhänen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;21: 103–107.
Torres-Padilla ME, Parfitt DE, Kouzarides T, et al. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature. 2007;445:214–218.
Dong C, Wilhelm D, Koopman P. Sox genes and cancer. Cytogenet Genome Res. 2004;105:442–447.
Li XL, Eishi Y, Bai YQ, et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 2004;24:257–263.
Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA. 2003;100:15178–15183.
Gu G, Yuan J, Wills M, et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 2007;67:4807–4815.
Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, et al. SOX2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol. 2007;20:474–481.
Rahnama F, Shafiei F, Gluckman PD, et al. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology. 2006;147:5275–5283.
Otsubo T, Akiyama Y, Yanagihara K, et al. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer. 2008;98: 824–831.
Zhang HJ, Siu MK, Wong ES Wong, et al. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. Placenta 2008;29:549–554.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, A.S.M., Siu, M.K.Y., Zhang, H. et al. Hypermethylation of SOX2 Gene in Hydatidiform Mole and Choriocarcinoma. Reprod. Sci. 15, 735–744 (2008). https://doi.org/10.1177/1933719108322433
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719108322433